Ryota Tanaka Selected Research

Adrenal Cortex Hormones (Corticosteroids)

1/2022	Evaluation of apremilast, an oral phosphodiesterase 4 inhibitor, for refractory cutaneous dermatomyositis: A phase 1b clinical trial.
9/2020	Cerebral venous thrombosis in COVID-19-associated coagulopathy: A case report.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ryota Tanaka Research Topics

Disease

39	Neoplasms (Cancer) 01/2024 - 02/2005
25	Stroke (Strokes) 06/2023 - 06/2002
24	Melanoma (Melanoma, Malignant) 01/2021 - 02/2014
20	Ischemic Stroke 06/2023 - 06/2002
13	Infarction (Infarctions) 09/2021 - 06/2002
12	Inflammation (Inflammations) 04/2024 - 09/2011
11	Infections 01/2023 - 06/2012
11	Hypertension (High Blood Pressure) 12/2022 - 03/2014
8	Chronic Renal Insufficiency 01/2024 - 05/2020
8	Hemorrhage 10/2023 - 01/2013
8	Ischemia 09/2021 - 03/2002
7	Neoplasm Metastasis (Metastasis) 01/2024 - 04/2016
6	Acute Kidney Injury (Acute Renal Failure) 01/2024 - 03/2014
6	Atrial Fibrillation 12/2022 - 01/2018
6	Lung Neoplasms (Lung Cancer) 06/2022 - 01/2008
6	Brain Ischemia (Cerebral Ischemia) 09/2021 - 03/2006
6	Cerebral Infarction 01/2017 - 06/2002
5	Myositis (Idiopathic Inflammatory Myopathies) 01/2024 - 01/2021
5	Dermatomyositis (Dermatopolymyositis) 01/2024 - 01/2021
5	Parkinson Disease (Parkinson's Disease) 01/2023 - 09/2015
5	Cognitive Dysfunction 12/2022 - 06/2006
5	Dermatitis 12/2022 - 01/2017
5	Orthostatic Hypotension (Postural Hypotension) 12/2022 - 09/2015
5	Chronic Kidney Failure (Chronic Renal Failure) 01/2021 - 12/2015
4	Hematologic Neoplasms (Hematological Malignancy) 01/2024 - 01/2018
4	Febrile Neutropenia 01/2024 - 01/2018
4	Atherosclerosis 06/2023 - 03/2013
4	Thrombophilia 06/2023 - 06/2002
4	Psoriasis (Pustulosis Palmaris et Plantaris) 12/2022 - 01/2017
4	Embolic Stroke 02/2021 - 02/2014
4	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 10/2018 - 01/2013
3	Hepatocellular Carcinoma (Hepatoma) 06/2024 - 10/2021
3	Virus Diseases (Viral Diseases) 04/2024 - 01/2014
3	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2024 - 01/2018
3	Pneumonia (Pneumonitis) 06/2022 - 01/2017
3	Renal Insufficiency (Renal Failure) 05/2022 - 02/2019
3	Pain (Aches) 04/2022 - 09/2015
3	Body Weight (Weight, Body) 10/2021 - 01/2021
3	Thrombocytopenia (Thrombopenia) 10/2021 - 01/2016
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021 - 01/2018
3	Fever (Fevers) 06/2018 - 06/2016
3	Lung Injury 01/2015 - 09/2011
3	Glucose Intolerance 01/2015 - 04/2009

Drug/Important Bio-Agent (IBA)

18	NivolumabIBA 04/2022 - 01/2016
13	Proteins (Proteins, Gene)FDA Link 01/2024 - 02/2005
13	Immune Checkpoint InhibitorsIBA 04/2022 - 01/2016
10	CytokinesIBA 01/2024 - 03/2006
9	Biomarkers (Surrogate Marker)IBA 11/2021 - 01/2016
8	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 04/2009
8	AntibodiesIBA 01/2021 - 11/2016
7	Monoclonal AntibodiesIBA 01/2024 - 02/2014
6	Anti-Bacterial Agents (Antibiotics)IBA 01/2024 - 01/2015
6	Cytochrome P-450 CYP3AIBA 01/2024 - 12/2015
6	AnticoagulantsIBA 12/2022 - 06/2002
6	Neuroprotective AgentsIBA 09/2021 - 10/2005
6	IpilimumabIBA 01/2021 - 11/2017
5	CreatinineIBA 01/2024 - 11/2014
5	hydroxide ionIBA 12/2022 - 09/2015
5	AdrenomedullinIBA 11/2021 - 11/2009
5	Cilostazol (Pletal)FDA LinkGeneric 02/2021 - 06/2006
5	ThioredoxinsIBA 09/2015 - 09/2011
5	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2015 - 11/2009
4	EnbucrilateIBA 11/2023 - 10/2020
4	Therapeutic UsesIBA 01/2023 - 06/2002
4	fibrin fragment D (D-dimer)IBA 01/2022 - 08/2014
4	C-Reactive ProteinIBA 01/2022 - 09/2015
4	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 02/2021 - 03/2014
4	Interleukin-6 (Interleukin 6)IBA 10/2020 - 01/2017
4	pembrolizumabIBA 06/2020 - 01/2018
4	DNA (Deoxyribonucleic Acid)IBA 01/2018 - 02/2006
3	3- carboxy- 4- methyl- 5- propyl- 2- furanpropanoic acidIBA 01/2024 - 05/2020
3	Hemoglobins (Hemoglobin)IBA 01/2024 - 04/2013
3	Cisplatin (Platino)FDA LinkGeneric 01/2024 - 03/2014
3	IndicanIBA 12/2023 - 04/2019
3	Parathyroid Hormone (Parathormone)IBA 12/2023 - 04/2019
3	Ethanol (Ethyl Alcohol)IBA 11/2023 - 10/2020
3	Linezolid (Zyvox)FDA Link 01/2023 - 01/2016
3	SodiumIBA 01/2023 - 01/2016
3	Imiquimod (Aldara)FDA LinkGeneric 12/2022 - 10/2020
3	Peptides (Polypeptides)IBA 05/2022 - 02/2019
3	AutoantibodiesIBA 04/2022 - 01/2021
3	LigandsIBA 04/2022 - 01/2016
3	Warfarin (Coumadin)FDA LinkGeneric 01/2022 - 06/2019
3	Voriconazole (Vfend)FDA LinkGeneric 01/2022 - 01/2021
3	Eicosapentaenoic AcidIBA 09/2020 - 07/2018
3	AlbuminsIBA 07/2020 - 04/2014
3	Programmed Cell Death 1 ReceptorIBA 05/2019 - 01/2018
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2019 - 01/2016
3	SteroidsIBA 11/2017 - 01/2013
3	Intravenous Immunoglobulins (IVIG)FDA Link 01/2017 - 09/2016

Therapy/Procedure

38	Therapeutics 01/2024 - 06/2002
9	Immunotherapy 04/2022 - 01/2016
5	Aftercare (After-Treatment) 01/2024 - 01/2017
5	Drug Therapy (Chemotherapy) 01/2024 - 01/2018
5	Kidney Transplantation 01/2021 - 12/2015
3	Hepatectomy 06/2024 - 01/2021
3	Stents 10/2023 - 01/2017
3	Radiotherapy 03/2021 - 04/2016
3	Injections 01/2021 - 01/2017
3	Operative Surgical Procedures 10/2020 - 01/2008